特定阶段的CAR介导信号产生来自诱导多能干细胞的原始类型,TCR-null的CAR T细胞
bioRxiv : the preprint server for biology
|December 9, 2024
概括
转基因诱导多能干细胞 (iPSCs) 可以产生仿真抗原受体 (CAR) T 细胞. 工程CAR表达时间允许T细胞发育和为增强的CAR T细胞疗法进行积极选择.
科学领域:
- 免疫学 免疫学 免疫学
- 干细胞生物学 干细胞生物学
- 细胞疗法细胞疗法
背景情况:
- 诱导多能干细胞 (iPSCs) 是全基化化学抗原受体 (CAR) T 细胞的潜在来源.
- 挑战包括T细胞发育期间的CAR信号传递和去除内源性T细胞受体 (TCR) 以防止全活性.
研究的目的:
- 开发一种方法,从iPSC中产生成熟的,常规的CAR T细胞.
- 为了克服来自iPSC的CAR T细胞生产的挑战,用于全基细胞疗法.
主要方法:
- 在iPSC中,工程阶段特定的CAR表达和信号的出现.
- 产生TCR-null的CD8αβCAR T细胞.
- 使用多模式测序来分析CAR T细胞发育和表型.
主要成果:
- 从iPSC中有效生成TCR-null,CD8αβ CAR T细胞.
- 卡尔T细胞表现出一种统一的,原始的T细胞表型.
- 与iPSC衍生效应记忆CAR T细胞相比,已证明具有优越的抗原特异性细胞毒性.
- 通过CAR介导的阳性选择导致了对原始T细胞发育的关键转录因子的持续上调.
结论:
- 精确控制CAR表达和信号对于开发"现成"iPSC衍生的细胞疗法至关重要.
- 这种方法有助于从iPSC中生产功能增强的CAR T细胞.
相关概念视频
T Cell Activation and Clonal Selection
658
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
658
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K


